Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Journal of Hematology & Oncology
Jasleen RandhawaSrdan Verstovsek
Cancer
Meetu AgrawalAlfonso Quintás-Cardama
Hematology/oncology Clinics of North America
Francesco PassamontiDomenica Caramazza
Therapeutic Advances in Hematology
Mohamad Bassam SonbolRamon V Tiu
Cancer
Alfonso Quintás-Cardama, Srdan Verstovsek